Edition:
United States

AstraZeneca leaves door ajar to Pfizer, despite hurdles

Share Slideshow
Photographer
� Darren Staples / Reuters

A sign is seen at an AstraZeneca site in Macclesfield, central England April 28, 2014. REUTERS/Darren Staples

A sign is seen at an AstraZeneca site in Macclesfield, central England April 28, 2014. REUTERS/Darren Staples
Close
1 / 2
Photographer
� Andrew Kelly / Reuters

A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly

A man walks past Pfizer's world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly
Close
2 / 2

All Collections

Munich shooting attack

Saturday, July 23, 2016

All Collections

Hillary chooses Kaine

Friday, July 22, 2016

All Collections

Best of Comic-Con

Friday, July 22, 2016

All Collections

Police funerals in Baton Rouge

Friday, July 22, 2016

All Collections

RNC closing night

Friday, July 22, 2016

All Collections

Frontlines of Libya

Friday, July 22, 2016

All Collections

Rio's Olympic venues

Friday, July 22, 2016

All Collections

On the RNC floor

Friday, July 22, 2016